Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

  • This share is currently suspended. It was suspended at a price of 0.112
  • There is currently no data for SCE

Trading Update

7 Dec 2015 07:00

RNS Number : 1267I
Surface Transforms PLC
07 December 2015
 

Surface Transforms Plc

("Surface Transforms" or the "Company")

 

Trading Update

 

Surface Transforms (AIM:SCE) is pleased to provide the following pre-close trading update, for the six months to 30 November 2015 being better than our expectations.

 

Revenue for the period was £782k (2014: £623k) being approximately 26% higher than the corresponding period last year. The Company expects that this higher revenue, will result in an EBITDA loss (inclusive of the R&D tax credit booked in the first half of the year) being significantly lower than the same period last year.

 

The increased revenue was assisted by a catch up in sales following the furnace break down in May 2015 and approximately £107k from increased aircraft revenues, but within the core automotive sales, it is encouraging to note that there was a 60% increase in retrofit car sales and a 20% increase in near OEM car sales, equivalent to approximately £100k in aggregate between the comparable half year periods; the former reflecting new additional customers, the latter being increased sales to existing customers.

 

Cash was £523k at the half year end (2014: £132k) and £829k at the year ended 31 May 2015. However net current assets increased by £266k in the period and will convert to cash over the next few months demonstrating the business being close to operating cash break-even in the first half.

 

David Bundred, Chairman, said "these better than expected results are most encouraging. Additionally at the recent AGM, the Company was able to confirm further progress on the aerospace and five game changing automotive contract discussions. The Company continues to believe it will be able to announce automotive contract awards in 2016 and that it will meet sales, EBITDA and cash useage expectations for the full year to May 2016."

 

The Company expects to report its interim results for the six months ended 30 November in February 2016.

 

Enquiries

Surface Transforms plc

Dr. Kevin Johnson, CEO

+44 151 356 2141

David Bundred, Chairman

+44 7785 388 848

 

Cantor Fitzgerald Europe

David Foreman, Michael Reynolds (Corporate Finance)

+44 207 894 7000

David Banks , Tessa Sillars (Corporate Broking)

+44 207 894 7000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKADBFBDDKBK
Date   Source Headline
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1
19th Sep 20197:00 amRNSCapital Markets Day
18th Sep 201910:50 amRNSHolding(s) in Company
9th Sep 20197:00 amRNSPreliminary results and notice of AGM
5th Sep 20194:10 pmEQSHardman & Co Research: Surface Transforms (SCE): Rapid acceleration - 'game-change' announcements
27th Aug 20197:00 amRNSContract Agreement with German OEM 5
15th Aug 20197:00 amRNSChange of Financial Year End Date
16th Jul 20197:00 amRNSContract award from German OEM 5
28th Jun 20197:00 amRNSContract Awards and Commercial Settlement
16th May 20197:00 amRNSDirector/PDMR Shareholding
7th May 20199:05 amRNSSecond Price Monitoring Extn
7th May 20199:00 amRNSPrice Monitoring Extension
7th May 20197:00 amRNSTrading Update
28th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20195:05 pmRNSHolding(s) in Company
20th Mar 20197:00 amRNS£1.9 million placing
26th Feb 20197:00 amRNSInterim Results
11th Dec 20185:36 pmRNSResult of AGM
6th Dec 20187:00 amRNSExercise of Options and Director Dealing
5th Dec 20187:00 amRNSGrant of Options
4th Dec 20187:00 amRNSTrading & Operational Update
17th Sep 20187:00 amRNSPreliminary Results and Notice of AGM
10th Sep 20187:00 amRNSBoard appointment
4th Jul 20183:19 pmRNSGrant of options
3rd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20188:38 amRNS£1.5 Million Placing
13th Jun 20187:00 amRNSPre Close Trading, Customer and Operations Update
10th May 20187:00 amRNSDirector/PDMR Shareholding
12th Apr 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.